Citations to this article

Modulation of T-cell responses to alloantigens by TR6/DcR3
Jun Zhang, … , Paul A. Moore, Jiangping Wu
Jun Zhang, … , Paul A. Moore, Jiangping Wu
Published June 1, 2001
Citation Information: J Clin Invest. 2001;107(11):1459-1468. https://doi.org/10.1172/JCI12159.
View: Text | PDF
Article Article has an altmetric score of 6

Modulation of T-cell responses to alloantigens by TR6/DcR3

Abstract

TR6 (DcR3) is a new member of the TNF receptor (TNFR) family that lacks a transmembrane domain in its sequence, indicating that it is a secreted molecule. TR6 can bind to FasL and prevent FasL-induced apoptosis; it can also associate with LIGHT, another TNF family member. The role of TR6 in immune responses was investigated in this study. According to flow cytometry, recombinant human TR6-Fc binds to human LIGHT expressed on 293 cells or on activated human T cells and competes with the LIGHT receptor TR2 for the binding to LIGHT on these cells. Human TR6 could cross-react with mouse LIGHT in immunoprecipitation. TR6-Fc also downregulates cytotoxic T lymphocyte activity in vitro and graft-versus-host responses in mice. Moreover, TR6-Fc modulates lymphokine production by alloantigen-stimulated mouse T cells. TR6-Fc ameliorated rejection response to mouse heart allograft. These results indicate that TR6 can dampen T-cell responses to alloantigens. Such regulatory effects of TR6 probably occur via interference with interaction between pairs of related TNF and TNFR family members, LIGHT/TR2 being one of the possible candidate pairs.

Authors

Jun Zhang, Theodora W. Salcedo, Xiaochun Wan, Stephen Ullrich, Bugen Hu, Theresa Gregorio, Ping Feng, Shijie Qi, Huifang Chen, Yun Hee Cho, Yuling Li, Paul A. Moore, Jiangping Wu

×

Total citations by year

Year: 2022 2020 2019 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2006 2004 2002 Total
Citations: 1 2 1 2 3 1 2 3 5 3 2 1 2 1 3 1 33
Citation information

Citations to this article (33)

Title and authors Publication Year
Decoy Receptor 3 Suppresses T-Cell Priming and Promotes Apoptosis of Effector T-Cells in Acute Cell-Mediated Rejection: The Role of Reverse Signaling
Weng SC, Wen MC, Hsieh SL, Chen NJ, Tarng DC 		Frontiers in immunology 2022
Decoy Receptor 3 Promotes Preosteoclast Cell Death via Reactive Oxygen Species-Induced Fas Ligand Expression and the IL-1 α /IL-1 Receptor Antagonist Pathway
YJ Peng, CT Peng, YH Lin, GJ Lin, SH Huang, SJ Chen, HK Sytwu, CP Cheng 		Mediators of Inflammation 2020
Type‐1 immunity and endogenous immune regulators predominate in the airway transcriptome during chronic lung allograft dysfunction
CJ Iasella, A Hoji, I Popescu, J Wei, ME Snyder, Y Zhang, W Xu, V Iouchmanov, R Koshy, M Brown, M Fung, C Langelier, EA Lendermon, D Dugger, R Shah, J Lee, B Johnson, J Golden, LE Leard, ME Kleinhenz, S Kilaru, SR Hays, JP Singer, PG Sanchez, MR Morrell, JM Pilewski, JR Greenland, K Chen, JF McDyer 		American Journal of Transplantation 2020
Reverse Signaling of Tumor Necrosis Factor Superfamily Proteins in Macrophages and Microglia: Superfamily Portrait in the Neuroimmune Interface
WH Lee, D Seo, SG Lim, K Suk 		Frontiers in immunology 2019
Crosstalk between signals initiated from TLR4 and cell surface BAFF results in synergistic induction of proinflammatory mediators in THP-1 cells
SG Lim, JK Kim, K Suk, WH Lee 		Scientific Reports 2017
Amelioration of amyloid-β-induced deficits by DcR3 in an Alzheimer’s disease model
YL Liu, WT Chen, YY Lin, PH Lu, SL Hsieh, IH Cheng 		Molecular Neurodegeneration 2017
Immunotherapeutic targeting of LIGHT/LTβR/HVEM pathway fully recapitulates the reduced cytotoxic phenotype of LIGHT-deficient T cells
ML Rio, C Fernandez-Renedo, O Chaloin, S Scheu, K Pfeffer, Y Shintani, JA Perez-Simon, P Schneider, JI Rodriguez-Barbosa 		mAbs 2016
DcR3 gene polymorphisms are associated with sporadic breast infiltrating ductal carcinoma in Northeast Chinese women
Z Fu, S Chen, S Liu, S Han, X Gao, D Li, D Li 		Oncotarget 2016
Decoy Receptor 3 (DcR3) as a Biomarker of Tumor Deterioration in Female Reproductive Cancers: A Meta-Analysis
Jiang M, Lin X, He R, Lin X, Liang L, Tang R, Xiong D, Wei K, Dang Y, Feng Z, Chen G 		Medical science monitor : international medical journal of experimental and clinical research 2016
Expression of decoy receptor 3 in kidneys is associated with allograft survival after kidney transplant rejection
SC Weng, KH Shu, MJ Wu, MC Wen, SL Hsieh, NJ Chen, DC Tarng 		Scientific Reports 2015
Mechanistic Basis for Functional Promiscuity in the TNF and TNF Receptor Superfamilies: Structure of the LIGHT:DcR3 Assembly
W Liu, C Zhan, H Cheng, PR Kumar, JB Bonanno, SG Nathenson, SC Almo 		Structure 2014
Therapeutic Blockade of LIGHT Interaction With Herpesvirus Entry Mediator and Lymphotoxin β Receptor Attenuates In Vivo Cytotoxic Allogeneic Responses:
ML Rio, C Fernandez-Renedo, S Scheu, K Pfeffer, Y Shintani, M Kronenberg, O Chaloin, P Schneider, JI Rodriguez-Barbosa 		Transplantation 2014
MANBA, CXCR5, SOX8, RPS6KB1 and ZBTB46 are genetic risk loci for multiple sclerosis
CM Lill, BM Schjeide, C Graetz, M Ban, A Alcina, MA Ortiz, J Perez, V Damotte, D Booth, AL de Lapuente, L Broer, M Schilling, DA Akkad, O Aktas, I Alloza, A Antiguedad, R Arroyo, P Blaschke, M Buttmann, A Chan, A Compston, I Cournu-Rebeix, T Dorner, JT Epplen, O Fernandez, LA Gerdes, L Guillot-Noel, HP Hartung, S Hoffjan, G Izquierdo, A Kemppinen, A Kroner, C Kubisch, T Kumpfel, SC Li, U Lindenberger, P Lohse, C Lubetzki, F Luessi, S Malhotra, J Mescheriakova, X Montalban, C Papeix, LF Paredes, P Rieckmann, E Steinhagen-Thiessen, A Winkelmann, UK Zettl, R Hintzen, K Vandenbroeck, G Stewart, B Fontaine, M Comabella, E Urcelay, F Matesanz, S Sawcer, L Bertram, F Zipp 		Brain 2013
The role of TL1A and DR3 in autoimmune and inflammatory diseases
Y Aiba, M Nakamura 		Mediators of Inflammation 2013
Reduction of decoy receptor 3 enhances TRAIL-mediated apoptosis in pancreatic cancer
W Wang, M Zhang, W Sun, S Yang, Y Su, H Zhang, C Liu, X Li, L Lin, S Kim, P Okunieff, Z Zhang, L Zhang 		PloS one 2013
Current Status of the Immunomodulation and Immunomediated Therapeutic Strategies for Multiple Sclerosis
SJ Chen, YL Wang, HC Fan, WT Lo, CC Wang, HK Sytwu 		Clinical and Developmental Immunology 2012
Triptolide triggers the apoptosis of pancreatic cancer cells via the downregulation of Decoy receptor 3 expression
W Wang, X Li, W Sun, L Zhang, M Zhang, B Hong, G Lv 		Journal of Cancer Research and Clinical Oncology 2012
TNFSF15 Modulates Neovascularization and Inflammation
Z Zhang, LY Li 		Cancer Microenvironment 2012
Decoy receptor 3, a novel inflammatory marker, and mortality in hemodialysis patients
SC Hung, TW Hsu, YP Lin, DC Tarng 		Clinical journal of the American Society of Nephrology : CJASN 2012
Immunologic Regulation in Pregnancy: From Mechanism to Therapeutic Strategy for Immunomodulation
SJ Chen, YL Liu, HK Sytwu 		Clinical and Developmental Immunology 2012
Genome-wide association study identifies two new susceptibility loci for atopic dermatitis in the Chinese Han population
LD Sun, FL Xiao, Y Li, WM Zhou, HY Tang, XF Tang, H Zhang, H Schaarschmidt, XB Zuo, R Foelster-Holst, SM He, M Shi, Q Liu, YM Lv, XL Chen, KJ Zhu, YF Guo, DY Hu, M Li, M Li, YH Zhang, X Zhang, JP Tang, BR Guo, H Wang, Y Liu, XY Zou, FS Zhou, XY Liu, G Chen, L Ma, SM Zhang, AP Jiang, XD Zheng, XH Gao, P Li, CX Tu, XY Yin, XP Han, YQ Ren, SP Song, ZY Lu, XL Zhang, Y Cui, J Chang, M Gao, XY Luo, PG Wang, X Dai, W Su, H Li, CP Shen, SX Liu, XB Feng, CJ Yang, GS Lin, ZX Wang, JQ Huang, X Fan, Y Wang, YX Bao, S Yang, JJ Liu, A Franke, S Weidinger, ZR Yao, XJ Zhang 		Nature Genetics 2011
Aberrant expression and function of death receptor-3 and death decoy receptor-3 in human cancer
Z Ge, AJ Sanders, L Ye, WG Jiang 		Experimental and therapeutic medicine 2011
Decoy Strategies: The Structure of TL1A:DcR3 Complex
C Zhan, Y Patskovsky, Q Yan, Z Li, U Ramagopal, H Cheng, M Brenowitz, X Hui, SG Nathenson, SC Almo 		Structure 2011
Stimulation of FasL Induces Production of Proinflammatory Mediators Through Activation of Mitogen-Activated Protein Kinases and Nuclear Factor-κB in THP-1 Cells
SM Lee, EJ Kim, K Suk, WH Lee 		Inflammation 2010
Polymorphisms of decoy receptor 3 are associated with risk of esophageal squamous cell carcinoma in Chinese Han
G Xiong, H Guo, K Wang, H Hu, D Wang, X Xu, X Guan, K Yang, Y Bai 		Tumor Biology 2010
Immunoregulation by tumor necrosis factor superfamily member LIGHT
Y Wang, M Zhu, M Miller, YX Fu 		Immunological Reviews 2009
Elevated serum decoy receptor 3 with enhanced T cell activation in systemic lupus erythematosus
CS Lee, CY Hu, HF Tsai, CS Wu, SL Hsieh, LC Liu, PN Hsu 		Clinical & Experimental Immunology 2008
Decoy Receptor 3 Is a Prognostic Factor in Renal Cell Cancer
Macher-Goeppinger S, Aulmann S, Wagener N, Funke B, Tagscherer KE, Haferkamp A, Hohenfellner M, Kim S, Autschbach F, Schirmacher P, Roth W 		Neoplasia (New York, N.Y.) 2008
The Lymphotoxin Pathway: Beyond Lymph Node Development
DD McCarthy, L Summers-Deluca, F Vu, S Chiu, Y Gao, JL Gommerman 		Immunologic Research 2006
Selective induction of tumor necrosis receptor factor 6/decoy receptor 3 release by bacterial antigens in human monocytes and myeloid dendritic cells
S Kim, WJ McAuliffe, LS Zaritskaya, PA Moore, L Zhang, B Nardelli 		Infection and immunity 2004
Transgenic Expression of Decoy Receptor 3 Protects Islets from Spontaneous and Chemical-induced Autoimmune Destruction in Nonobese Diabetic Mice
HH Sung, JH Juang, YC Lin, CH Kuo, JT Hung, A Chen, DM Chang, SY Chang, SL Hsieh, HK Sytwu 		Journal of Experimental Medicine 2004
The Role of LIGHT in T Cell-Mediated Immunity
J Wang, YX Fu 		Immunologic Research 2004
Differential Expression of LIGHT and Its Receptors in Human Placental Villi and Amniochorion Membranes
Gill RM, Ni J, Hunt JS 		The American Journal of Pathology 2002

Advertisement